Starzl’s innovative research and contributions to the medical field provide hope for today’s liver transplant donors and recipients
2017 was going to be a reset after the November 8th election with new members of Congress, the anticipated retirement of long-tenured federal agency staffers, Supreme Court Justice nominations and change in White House personnel. However...
The Global Liver Institute is proud to announce the recognition of president, Donna Cryer, as one of the most influential individuals in patient activism.
On the eve of ICER’s public meeting to discuss its evaluation of these treatments, National Pharmaceutical Council President Dan Leonard sat down with Ms. Cryer to ask her thoughts about ICER, value assessments and how patients can become more engaged in these evaluations.
Health insurers, public and private, should support the provision of care that taxpayers, employers – people – find valuable to optimizing health. However, all too often payer perspectives don’t align with those of patients, caregivers, and clinicians.